文献速递脑血管病

儿童急性卒中静脉tPA后颅内出血风险低

Risk of Intracranial Hemorrhage Following Intravenous tPA (Tissue-Type Plasminogen Activator) for Acute Stroke Is Low in Children.
PubMed 文献 · Stroke · 2019-12-17

本研究回顾性收集16个曾参与TIPS试验的中心中因神经影像确诊的急性动脉缺血性卒中而接受静脉tPA治疗的儿童数据,以评估症状性颅内出血(SICH)风险。

要点

  • 儿童急性缺血性卒中在发病4.5小时内静脉tPA,症状性颅内出血风险低。
  • 无论先验假设如何,SICH风险<15%的概率至少98%,<10%的概率至少93%。

核心结论

  • 儿童急性动脉缺血性卒中在症状出现4.5小时内接受静脉tPA,症状性颅内出血的总体风险低。

研究设计与样本

  • 回顾性研究,从16个曾参与TIPS试验的中心收集神经影像确诊的急性动脉缺血性卒中并接受静脉tPA治疗的儿童数据。
  • 要求参与中心报告所有接受静脉tPA治疗的儿童,以减少报告偏倚。
  • SICH定义为ECASS II型脑实质血肿2型或tPA给药后36小时内与神经功能恶化相关的任何颅内出血。
  • 采用贝叶斯beta-二项模型估计tPA后SICH风险,先验分布基于年轻成人风险水平(1.7%),并以无信息先验和保守先验进行稳健性检验。

主要发现

  • tPA在卒中发病后2至4.5小时内给药(中位3.0小时)。
  • 无患者发生SICH,2例儿童出现鼻出血。
  • 估计儿童tPA后SICH风险为2.1%(95%最高后验密度区间0.0%-6.7%;众数0.9%)。
  • 无论先验假设如何,SICH风险<15%的概率至少98%,<10%的概率至少93%。

关键数值与推荐

  • SICH定义:ECASS II型脑实质血肿2型或tPA给药后36小时内与神经功能恶化相关的任何颅内出血。
  • 估计SICH风险2.1%(95%最高后验密度区间0.0%-6.7%;众数0.9%)。
  • SICH风险<15%的概率至少98%,<10%的概率至少93%。

临床怎么用

  • 对于儿童急性动脉缺血性卒中,在发病4.5小时内可考虑静脉tPA治疗,但需结合机构方案并充分评估获益与风险。
  • 治疗决策时应关注症状性颅内出血风险,尽管本研究显示风险较低。

局限性

  • 数据来自曾参与TIPS试验的中心,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Data regarding the safety and efficacy of intravenous tPA (tissue-type plasminogen activator) in childhood acute arterial ischemic stroke are inadequate. The TIPS trial (Thrombolysis in Pediatric Stroke; National Institutes of Health grant R01NS065848)-a prospective safety and dose-finding trial of intravenous tPA in acute childhood stroke-was closed for lack of accrual. TIPS sites have subsequently treated children with acute stroke in accordance with established institutional protocols supporting data collection on outcomes. Methods- Data on children treated with intravenous tPA for neuroimaging-confirmed arterial ischemic stroke were collected retrospectively from 16 former TIPS sites to establish preliminary safety data. Participating sites were required to report all children who were treated with intravenous tPA to minimize reporting bias. Symptomatic intracranial hemorrhage (SICH) was defined as ECASS (European Cooperative Acute Stroke Study) II parenchymal hematoma type 2 or any intracranial hemorrhage associated with neurological deterioration within 36 following tPA administration. A Bayesian beta-binomial model for risk of SICH following intravenous tPA was fit using a prior distribution based on the risk level in young adults (1.7%); to test for robustness, the model was also fit with uninformative and conservative priors. Results- Twenty-six children (age range, 1.1-17 years; median, 14 years; 12 boys) with stroke and a median pediatric National Institutes of Health Stroke Scale score of 14 were treated with intravenous tPA within 2 to 4.5 hours (median, 3.0 hours) after stroke onset. No patient had SICH. Two children developed epistaxis. Conclusions- The estimated risk of SICH after tPA in children is 2.1% (95% highest posterior density interval, 0.0%-6.7%; mode, 0.9%). Regardless of prior assumption, there is at least a 98% chance that the risk is <15% and at least a 93% chance that the risk is <10%. These results suggest that the overall risk of SICH after intravenous tPA in children with acute arterial ischemic stroke, when given within 4.5 hours after symptom onset, is low.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Amlie-Lefond C, Shaw DWW, Cooper A, et al. Risk of Intracranial Hemorrhage Following Intravenous tPA (Tissue-Type Plasminogen Activator) for Acute Stroke Is Low in Children. Stroke. 2019. PMID: 31842706. doi:10.1161/STROKEAHA.119.027225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。